131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
Clinical trial NCT05064306 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT05064306
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.